Raub Brock Capital Management LP Sells 1,037 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Raub Brock Capital Management LP lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 31,592 shares of the healthcare conglomerate's stock after selling 1,037 shares during the period. UnitedHealth Group accounts for 3.7% of Raub Brock Capital Management LP's investment portfolio, making the stock its 13th biggest holding. Raub Brock Capital Management LP's holdings in UnitedHealth Group were worth $16,546,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the fourth quarter worth $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $32,000. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on UNH. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. HSBC reiterated a "reduce" rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Morgan Stanley cut their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Finally, Wolfe Research decreased their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $426.52.

Insider Buying and Selling at UnitedHealth Group

In related news, Director John H. Noseworthy bought 300 shares of the stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company's stock, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

UNH traded up $1.48 during midday trading on Tuesday, hitting $309.14. 10,740,812 shares of the company traded hands, compared to its average volume of 7,247,092. The company's 50-day moving average is $381.74 and its 200 day moving average is $470.20. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a market capitalization of $280.43 billion, a PE ratio of 19.94, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the firm posted $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.